BioWorld

May 6, 2002

View Archived Issues

Immunex Sells Leukine For $380M In Preparation For Amgen Merger

In another step toward completing the merger of Immunex Corp. and Amgen Inc., the former on Friday said it has found a buyer for its cancer drug, Leukine. (BioWorld Today) Read More

Trimeris Looks For New Fusion Inhibitors Through Neokimia Deal

Read More

Smart’ Thermoplastic Surgical Sutures Inserted Loosely Inside Incision Tighten Automatically

Read More

Thios Completes $15M Round To Work On Role Of Sulfation

Read More

Other News To Note

Read More

Appointments And Advancements

Read More